Evidence map›Paper›PMID 41872133›Full record

ArticleCell death & disease2026

The amino acid transporter LAT1 coordinates proper motor function at the perinatal stage.

Koki Sadamori, Manami Hiraiwa, Tetsuhiro Horie, Kazuya Tokumura, Kazuya Fukasawa, Kentaro Sahashi, Soji Hayashida, Takuya Kubo, Makoto Yoshimoto, Shohei Tsuji and 3 more

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Koki Sadamori *Department of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Manami Hiraiwa *Department of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Tetsuhiro HorieMedical Research Institute, Kanazawa Medical University, Kahoku, Japan.ORCID http://orcid.org/0000-0002-2095-9425
Kazuya TokumuraDepartment of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Kazuya FukasawaDepartment of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Kentaro SahashiDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Soji HayashidaDepartment of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Takuya KuboDepartment of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Makoto YoshimotoDepartment of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Shohei TsujiDepartment of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, Japan.
Yasuhito IshigakiMedical Research Institute, Kanazawa Medical University, Kahoku, Japan.
Masahisa KatsunoDepartment of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Eiichi HinoiDepartment of Bioactive Molecules, Pharmacology, Gifu Pharmaceutical University, Gifu, Japan. hinoi-e@gifu-pu.ac.jp.ORCID http://orcid.org/0000-0002-1298-8293

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 20H03407
6 · The paper itself

Abstract

L-type amino acid transporter 1 (LAT1, encoded by Slc7a5) contributes to amino acid homeostasis and signaling in numerous cell types. Several lines of evidence implicate LAT1 in mammalian central nervous system development, but its functional significance in specific neuronal subtypes is largely unknown. Here, we demonstrate that LAT1/Slc7a5 expression in synapsin 1 (Syn1)-expressing neurons is essential for motor circuit development and motor coordination at the perinatal stage. Mice lacking Slc7a5 in Syn1-expressing neurons exhibited progressive motor coordination deficits and early postnatal lethality. These deficits were associated with selective degeneration of lower spinal motor neurons, reactive gliosis, skeletal muscle atrophy, and maldevelopment of neuromuscular junctions (NMJs), but no abnormalities in gross brain structure or neuronal viability. Pharmacological inhibition of apoptosis prolonged the survival of Slc7a5-deficient mice and reduced both lower motor neuron loss and NMJ maldevelopment. Furthermore, multi-cohort transcriptome analyses revealed inactivation of amino acid transport activity along with the downregulation of Slc7a5 expression in motor neurons of spinal muscular atrophy model mice. These results suggest that the amino acid transport system is essential for the survival and function of lower spinal motor neurons during early postnatal development, and identifies LAT1 as a potential therapeutic target for early-onset motor neuron diseases.

Indexed as

Large Neutral Amino Acid-Transporter 1Motor NeuronsAnimalsApoptosisMiceMice, KnockoutNeuromuscular JunctionLarge Neutral Amino Acid-Transporter 1Slc7a5 protein, mouse

Identifiers

PMID41872133
PMCPMC13039311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.